Sonia Guedan

6PUBLICATIONS
48CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 29, 2025
Unlocking the potential of engineered immune cell therapy for solid tumors.

Víctor Albarrán-Fernández, Laura Angelats, Julio Delgado

|Apr 26, 2024
CAR affinity modulates the sensitivity of CAR-T cells to PD-1/PD-L1-mediated inhibition.

Irene Andreu-Saumell, Alba Rodriguez-Garcia, Vanessa Mühlgrabner

|Apr 03, 2023
Type I Interferon Signaling via the EGR2 Transcriptional Regulator Potentiates CAR T Cell-Intrinsic Dysfunction.

In-Young Jung, Robert L Bartoszek, Andrew J Rech

|Apr 01, 2022
Overcoming CAR-Mediated CD19 Downmodulation and Leukemia Relapse with T Lymphocytes Secreting Anti-CD19 T-cell Engagers.

Belén Blanco, Ángel Ramírez-Fernández, Clara Bueno

|Oct 18, 2021
Choosing the Right Tool for Genetic Engineering: Clinical Lessons from Chimeric Antigen Receptor-T Cells.

Melita Irving, Evripidis Lanitis, Denis Migliorini

|Jul 04, 2019
Immobilizing A Moving Target: CAR T Cells Hit CD22.

Sonia Guedan, Julio Delgado

Pageof 1

Frequent Collaborators

2 joint publications

Aleix Prat

1 joint publications

Belén Blanco

1 joint publications

Patricia Fuentes

1 joint publications

Óscar Aguilar-Sopeña